Department of Surgery

Medicine & Life Sciences

1. Transplants 100%
2. Liver Transplantation 74%
3. Kidney 62%
4. Allografts 56%
5. Transplant Recipients 50%
6. Tissue Donors 48%
7. T-Lymphocytes 41%
8. Kidney Transplantation 40%
9. Neoplasms 40%
10. Surgeons 34%
11. Mammaplasty 34%
12. Therapeutics 33%
13. Transplantation 32%
14. Living Donors 31%
15. Pancreas Transplantation 30%
16. Survival 27%
17. Pancreas 26%
18. Mortality 22%
19. Wounds and Injuries 22%
20. Oocytes 20%
21. Breast 20%
22. Lung 19%
23. Liver 18%
24. Macrophages 18%
25. Immunosuppression 18%
26. Free Tissue Flaps 18%
27. Veterans 18%
28. Graft Survival 17%
29. Xenopus 17%
30. Genes 16%
31. Hepatocellular Carcinoma 16%
32. Sirolimus 16%
33. RNA 16%
34. Cyclosporine 16%
35. Graft Rejection 16%
36. Skin 16%
37. Regulatory T-Lymphocytes 15%
38. Infections 15%
39. Proteins 15%
40. Incidence 15%
41. Transplantation Tolerance 15%
42. Technology 15%
43. Tuberculosis 14%
44. Antibodies 14%
45. Breast Neoplasms 14%
46. Recurrence 14%
47. Equipment and Supplies 14%
48. Population 14%
49. Morbidity 14%
50. HIV 14%
51. Blood Vessels 14%
52. Xenopus laevis 13%
53. Organ Transplantation 13%
54. Heart 13%
55. Hand 13%
56. Pediatrics 13%
57. Tacrolimus 12%
58. Pharmaceutical Preparations 12%
59. Herniorrhaphy 12%
60. Pancreatic Neoplasms 12%
61. Immunosuppressive Agents 12%
62. Databases 12%
63. Coronavirus 12%
64. thymoglobulin 12%
65. Genome 12%
66. Costs and Cost Analysis 11%
67. Peritoneal Neoplasms 11%
68. African Americans 11%
69. Bariatric Surgery 11%
70. Lymphocytes 11%
71. Perforator Flap 11%
72. Safety 11%
73. Delivery of Health Care 11%
74. Guidelines 11%
75. Germ Cells 11%
76. In Vitro Techniques 11%
77. Neoplasm Metastasis 11%
78. Physicians 10%
79. Health 10%
80. Pandemics 10%
81. Messenger RNA 10%
82. Odds Ratio 10%
83. Cohort Studies 10%
84. Robotics 10%
85. Intensive Care Units 10%
86. Education 10%
87. Drainage 10%
88. Biopsy 9%
89. Registries 9%
90. Quality Improvement 9%
91. Muscles 9%
92. Serum 9%
93. Mycobacterium tuberculosis 9%
94. Dendritic Cells 9%
95. Swine 9%
96. Abdominal Wall 9%
97. Mastectomy 9%
98. Acellular Dermis 9%
99. Adenocarcinoma 9%
100. Length of Stay 8%